GenScript wins Best CDMO award for the third time
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The facility will manufacture its Herceptin biosimilar, Tuznue
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
The company will manufacture a cancer immunotherapy product from 2022
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
This is Enzene Biosciences third biosimilar to be approved
Subscribe To Our Newsletter & Stay Updated